These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Hypersensitivity pneumonitis following intravesical bacille Calmette-Guérin immunotherapy for superficial bladder cancer. Um SJ; Lee SK; Yang DK J Investig Allergol Clin Immunol; 2009; 19(3):230-2. PubMed ID: 19610267 [TBL] [Abstract][Full Text] [Related]
12. [A Case Diagnosed as Iatrogenic Vesical Tuberculosis 4 Years after Intravesical Immunotherapy Using Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Carcinoma]. Kudo T; Iwasa N; Maeda S; Mitarai S Kansenshogaku Zasshi; 2016 Nov; 90(6):809-13. PubMed ID: 30277373 [TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity pneumonitis as a complication of intravesical BCG therapy for bladder cancer. Carrasco Hernández L; Castaño Núñez ÁL; Rodríguez Portal JA Arch Bronconeumol; 2016 Aug; 52(8):445-6. PubMed ID: 26920491 [No Abstract] [Full Text] [Related]
14. New-onset psoriasis and psoriatic arthritis in a patient treated with Bacillus Calmette-Guérin (BCG) immunotherapy. Dudelzak J; Curtis AR; Sheehan DJ; Lesher JL J Drugs Dermatol; 2008 Jul; 7(7):684. PubMed ID: 18664162 [No Abstract] [Full Text] [Related]
15. Miliary pulmonary infection after BCG intravesical instillation: a rare, misdiagnosed and mistreated complication. Calleris G; Marra G; Corcione S; Oderda M; Cardellino C; Audagnotto S; Frea B; De Rosa FG; Gontero P Infez Med; 2017 Dec; 25(4):366-370. PubMed ID: 29286018 [TBL] [Abstract][Full Text] [Related]